| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Screening Assays | 14 | 2025 | 113 | 3.720 |
Why?
|
| Receptors, Androgen | 14 | 2020 | 402 | 2.850 |
Why?
|
| Single-Cell Analysis | 8 | 2024 | 314 | 2.740 |
Why?
|
| Estrogen Receptor alpha | 17 | 2023 | 424 | 2.270 |
Why?
|
| Transcription, Genetic | 17 | 2023 | 1378 | 2.030 |
Why?
|
| Endocrine Disruptors | 3 | 2022 | 53 | 1.950 |
Why?
|
| Microscopy | 8 | 2023 | 122 | 1.900 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2025 | 589 | 1.610 |
Why?
|
| Receptors, Estrogen | 10 | 2023 | 714 | 1.580 |
Why?
|
| Androgens | 5 | 2020 | 268 | 1.470 |
Why?
|
| HeLa Cells | 30 | 2020 | 684 | 1.430 |
Why?
|
| Androgen Receptor Antagonists | 6 | 2016 | 40 | 1.370 |
Why?
|
| Violence | 5 | 2025 | 126 | 1.370 |
Why?
|
| Cell Nucleus | 14 | 2011 | 551 | 1.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2022 | 748 | 1.020 |
Why?
|
| Benzhydryl Compounds | 3 | 2017 | 72 | 1.000 |
Why?
|
| Software | 2 | 2024 | 711 | 0.920 |
Why?
|
| Toxicology | 1 | 2023 | 8 | 0.830 |
Why?
|
| Antisocial Personality Disorder | 2 | 2021 | 65 | 0.820 |
Why?
|
| Nuclear Matrix | 5 | 2015 | 17 | 0.780 |
Why?
|
| Nuclear Receptor Coactivator 3 | 6 | 2020 | 253 | 0.780 |
Why?
|
| Drug Discovery | 2 | 2023 | 172 | 0.780 |
Why?
|
| Wounds, Gunshot | 4 | 2024 | 141 | 0.750 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2020 | 679 | 0.730 |
Why?
|
| Gene Expression Regulation | 7 | 2023 | 2309 | 0.720 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 355 | 0.660 |
Why?
|
| Transcription Factors | 12 | 2023 | 2342 | 0.650 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2018 | 144 | 0.650 |
Why?
|
| Down-Regulation | 2 | 2019 | 648 | 0.640 |
Why?
|
| Trialkyltin Compounds | 1 | 2019 | 7 | 0.630 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2019 | 16 | 0.630 |
Why?
|
| Chromatin | 8 | 2019 | 473 | 0.630 |
Why?
|
| Alleles | 2 | 2023 | 1609 | 0.630 |
Why?
|
| Adipocytes | 4 | 2013 | 167 | 0.610 |
Why?
|
| Aggression | 1 | 2021 | 220 | 0.600 |
Why?
|
| Estrogen Receptor beta | 4 | 2017 | 81 | 0.580 |
Why?
|
| Cell Line | 13 | 2024 | 2564 | 0.580 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2016 | 90 | 0.560 |
Why?
|
| Hepatocytes | 1 | 2019 | 231 | 0.560 |
Why?
|
| Phenols | 2 | 2017 | 64 | 0.550 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2017 | 14 | 0.540 |
Why?
|
| src-Family Kinases | 4 | 2016 | 90 | 0.540 |
Why?
|
| Humans | 88 | 2025 | 126923 | 0.540 |
Why?
|
| Aurora Kinase A | 3 | 2024 | 35 | 0.520 |
Why?
|
| Transcriptional Activation | 7 | 2024 | 412 | 0.520 |
Why?
|
| Ligands | 9 | 2017 | 477 | 0.500 |
Why?
|
| Estradiol | 5 | 2010 | 476 | 0.500 |
Why?
|
| Prostatic Neoplasms | 5 | 2016 | 1396 | 0.480 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2397 | 0.470 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2013 | 105 | 0.470 |
Why?
|
| Biological Assay | 2 | 2014 | 106 | 0.460 |
Why?
|
| Cell Line, Tumor | 19 | 2021 | 3499 | 0.460 |
Why?
|
| Polymers | 1 | 2016 | 109 | 0.460 |
Why?
|
| Mitosis | 3 | 2020 | 190 | 0.450 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1166 | 0.440 |
Why?
|
| Dihydrotestosterone | 4 | 2020 | 72 | 0.430 |
Why?
|
| Databases, Pharmaceutical | 1 | 2014 | 6 | 0.420 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2019 | 1596 | 0.420 |
Why?
|
| Histone Acetyltransferases | 6 | 2020 | 224 | 0.420 |
Why?
|
| Database Management Systems | 1 | 2014 | 27 | 0.420 |
Why?
|
| Firearms | 3 | 2024 | 56 | 0.420 |
Why?
|
| Anilides | 4 | 2010 | 52 | 0.410 |
Why?
|
| Adipogenesis | 2 | 2012 | 79 | 0.410 |
Why?
|
| Proteome | 1 | 2015 | 273 | 0.410 |
Why?
|
| MCF-7 Cells | 5 | 2017 | 207 | 0.410 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 61 | 0.410 |
Why?
|
| Genetic Variation | 3 | 2016 | 1508 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 774 | 0.400 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 988 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 321 | 0.390 |
Why?
|
| Androgen Antagonists | 3 | 2010 | 107 | 0.390 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2013 | 59 | 0.380 |
Why?
|
| RNA, Messenger | 4 | 2020 | 2538 | 0.380 |
Why?
|
| Cell Cycle | 3 | 2011 | 587 | 0.380 |
Why?
|
| Green Fluorescent Proteins | 10 | 2020 | 376 | 0.380 |
Why?
|
| DNA-Binding Proteins | 6 | 2020 | 1888 | 0.360 |
Why?
|
| Epidermal Growth Factor | 2 | 2008 | 111 | 0.340 |
Why?
|
| Trans-Activators | 6 | 2007 | 675 | 0.340 |
Why?
|
| Internet | 1 | 2014 | 402 | 0.340 |
Why?
|
| Tamoxifen | 4 | 2010 | 344 | 0.330 |
Why?
|
| Glucocorticoids | 1 | 2012 | 336 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2018 | 1932 | 0.320 |
Why?
|
| Nuclear Proteins | 5 | 2020 | 1204 | 0.320 |
Why?
|
| Animals | 37 | 2025 | 33111 | 0.310 |
Why?
|
| PPAR gamma | 4 | 2015 | 86 | 0.310 |
Why?
|
| Genes, Reporter | 5 | 2013 | 345 | 0.290 |
Why?
|
| Nuclear Receptor Coactivator 1 | 7 | 2015 | 160 | 0.280 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2025 | 58 | 0.280 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2021 | 234 | 0.270 |
Why?
|
| Phenotype | 4 | 2024 | 4305 | 0.270 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2024 | 252 | 0.270 |
Why?
|
| Signal Transduction | 12 | 2024 | 4478 | 0.270 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 87 | 0.270 |
Why?
|
| Trophoblasts | 2 | 2019 | 113 | 0.270 |
Why?
|
| Homeostasis | 1 | 2011 | 689 | 0.250 |
Why?
|
| Metribolone | 1 | 2006 | 28 | 0.250 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2886 | 0.250 |
Why?
|
| Aurora Kinases | 3 | 2017 | 26 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 1098 | 0.240 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2006 | 110 | 0.240 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2025 | 22 | 0.230 |
Why?
|
| Estrogens | 4 | 2020 | 423 | 0.230 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 162 | 0.230 |
Why?
|
| Organoids | 2 | 2025 | 282 | 0.230 |
Why?
|
| Active Transport, Cell Nucleus | 5 | 2014 | 112 | 0.220 |
Why?
|
| Mice | 19 | 2025 | 17627 | 0.220 |
Why?
|
| Machine Learning | 2 | 2020 | 325 | 0.220 |
Why?
|
| Phosphorylation | 9 | 2014 | 1536 | 0.220 |
Why?
|
| Lac Operon | 2 | 2002 | 90 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 4 | 2014 | 985 | 0.220 |
Why?
|
| Missouri | 4 | 2025 | 41 | 0.220 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2024 | 9 | 0.210 |
Why?
|
| Multienzyme Complexes | 2 | 2002 | 77 | 0.210 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 69 | 0.210 |
Why?
|
| DNA | 3 | 2020 | 1421 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 2 | 2002 | 105 | 0.210 |
Why?
|
| Placenta | 2 | 2019 | 511 | 0.210 |
Why?
|
| Transfection | 4 | 2008 | 947 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 7 | 2010 | 720 | 0.210 |
Why?
|
| Retinal Vessels | 4 | 1988 | 51 | 0.210 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 101 | 0.200 |
Why?
|
| Qualitative Research | 2 | 2024 | 659 | 0.200 |
Why?
|
| Goals | 1 | 2024 | 122 | 0.200 |
Why?
|
| Protein Folding | 1 | 2004 | 214 | 0.200 |
Why?
|
| Fibroblasts | 4 | 2024 | 820 | 0.200 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 566 | 0.200 |
Why?
|
| Biological Transport | 2 | 2001 | 327 | 0.200 |
Why?
|
| Cilia | 2 | 2021 | 76 | 0.200 |
Why?
|
| Point Mutation | 1 | 2004 | 335 | 0.200 |
Why?
|
| Carrier Proteins | 3 | 2016 | 1011 | 0.200 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2005 | 110 | 0.200 |
Why?
|
| Oxidative Stress | 3 | 2024 | 756 | 0.200 |
Why?
|
| Algorithms | 3 | 2020 | 1633 | 0.200 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2024 | 134 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2017 | 1758 | 0.190 |
Why?
|
| Inclusion Bodies | 1 | 2002 | 36 | 0.190 |
Why?
|
| Behavior, Addictive | 1 | 2023 | 59 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 3 | 2017 | 234 | 0.190 |
Why?
|
| Hospitals, University | 1 | 2022 | 103 | 0.190 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 677 | 0.190 |
Why?
|
| Support Vector Machine | 2 | 2012 | 23 | 0.190 |
Why?
|
| Lipolysis | 2 | 2013 | 73 | 0.190 |
Why?
|
| RNA | 2 | 2021 | 519 | 0.180 |
Why?
|
| Crime Victims | 1 | 2023 | 69 | 0.180 |
Why?
|
| Quality Control | 1 | 2022 | 115 | 0.180 |
Why?
|
| Survivors | 1 | 2024 | 345 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 378 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 2582 | 0.180 |
Why?
|
| Intestines | 1 | 2025 | 578 | 0.180 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2021 | 8 | 0.180 |
Why?
|
| RNA Splicing Factors | 1 | 2021 | 52 | 0.170 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2021 | 16 | 0.170 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 658 | 0.170 |
Why?
|
| Histones | 4 | 2012 | 503 | 0.170 |
Why?
|
| Virus Latency | 1 | 2021 | 61 | 0.170 |
Why?
|
| Recurrence | 1 | 2024 | 1418 | 0.170 |
Why?
|
| ErbB Receptors | 2 | 2014 | 285 | 0.170 |
Why?
|
| Oligonucleotide Probes | 1 | 2020 | 86 | 0.170 |
Why?
|
| Suicide | 1 | 2023 | 201 | 0.170 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 754 | 0.170 |
Why?
|
| Adenosine | 1 | 2021 | 126 | 0.170 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 652 | 0.170 |
Why?
|
| Mutation | 8 | 2019 | 5944 | 0.170 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2020 | 14 | 0.170 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 93 | 0.160 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 2011 | 26 | 0.160 |
Why?
|
| Bias | 1 | 2021 | 135 | 0.160 |
Why?
|
| Protein Binding | 5 | 2020 | 1663 | 0.160 |
Why?
|
| Luminescent Proteins | 6 | 2004 | 155 | 0.160 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 49 | 0.160 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2020 | 16 | 0.160 |
Why?
|
| Quinolines | 1 | 2021 | 111 | 0.160 |
Why?
|
| Serine | 2 | 2013 | 160 | 0.160 |
Why?
|
| Arginine | 2 | 2013 | 335 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 3 | 2014 | 216 | 0.160 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 33 | 0.160 |
Why?
|
| Imidazoles | 2 | 2021 | 218 | 0.160 |
Why?
|
| Prolactin | 2 | 2013 | 111 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2021 | 2895 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2019 | 42 | 0.160 |
Why?
|
| Proteostasis | 1 | 2020 | 34 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 90 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 272 | 0.150 |
Why?
|
| Myocardium | 1 | 2024 | 847 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 3 | 2017 | 1001 | 0.150 |
Why?
|
| United States | 4 | 2023 | 11318 | 0.150 |
Why?
|
| Molecular Structure | 2 | 2017 | 306 | 0.150 |
Why?
|
| DNA Damage | 2 | 2020 | 498 | 0.150 |
Why?
|
| Tosyl Compounds | 3 | 2008 | 24 | 0.150 |
Why?
|
| Automation | 2 | 2011 | 65 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2021 | 330 | 0.150 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2019 | 78 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 4 | 2006 | 308 | 0.150 |
Why?
|
| Pyridones | 2 | 2017 | 137 | 0.150 |
Why?
|
| Peptides | 1 | 2002 | 829 | 0.150 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 10 | 0.150 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 193 | 0.140 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 219 | 0.140 |
Why?
|
| Receptors, Progesterone | 2 | 2015 | 663 | 0.140 |
Why?
|
| Nitriles | 3 | 2008 | 149 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 482 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 478 | 0.140 |
Why?
|
| Antibody Specificity | 2 | 2015 | 196 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 477 | 0.140 |
Why?
|
| Pigment Epithelium of Eye | 3 | 1986 | 36 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2020 | 212 | 0.140 |
Why?
|
| Movement | 1 | 2019 | 143 | 0.140 |
Why?
|
| Genetic Markers | 1 | 2019 | 599 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2013 | 420 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 835 | 0.140 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 345 | 0.140 |
Why?
|
| Hydroquinones | 1 | 2017 | 12 | 0.140 |
Why?
|
| HIV-1 | 1 | 2021 | 469 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 315 | 0.130 |
Why?
|
| RNA Interference | 4 | 2015 | 493 | 0.130 |
Why?
|
| Female | 22 | 2025 | 68418 | 0.130 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 357 | 0.130 |
Why?
|
| Prevalence | 2 | 2021 | 2592 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2015 | 49 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 228 | 0.130 |
Why?
|
| Precision Medicine | 2 | 2011 | 345 | 0.130 |
Why?
|
| Male | 17 | 2025 | 62623 | 0.130 |
Why?
|
| Adolescent | 6 | 2025 | 20032 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 437 | 0.130 |
Why?
|
| Benzamides | 1 | 2017 | 120 | 0.130 |
Why?
|
| Mediator Complex | 2 | 2015 | 55 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 946 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1853 | 0.130 |
Why?
|
| Hexosamines | 1 | 2016 | 18 | 0.120 |
Why?
|
| 3T3-L1 Cells | 2 | 2013 | 52 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2019 | 332 | 0.120 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 17 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 57 | 0.120 |
Why?
|
| Antibody Affinity | 1 | 2015 | 42 | 0.120 |
Why?
|
| Hybridomas | 1 | 2015 | 38 | 0.120 |
Why?
|
| Transcription Factor Pit-1 | 2 | 2006 | 2 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 200 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 1206 | 0.120 |
Why?
|
| Atlases as Topic | 1 | 2015 | 20 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 372 | 0.120 |
Why?
|
| DNA Repair | 1 | 2019 | 549 | 0.120 |
Why?
|
| Endometrium | 1 | 2018 | 265 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2016 | 167 | 0.120 |
Why?
|
| Adipocytes, White | 1 | 2015 | 26 | 0.120 |
Why?
|
| Cytoplasm | 3 | 2020 | 249 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2015 | 31 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 147 | 0.110 |
Why?
|
| Zika Virus | 1 | 2017 | 151 | 0.110 |
Why?
|
| Germ Cells | 1 | 2016 | 197 | 0.110 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 84 | 0.110 |
Why?
|
| Quinazolines | 1 | 2016 | 179 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2017 | 294 | 0.110 |
Why?
|
| Cytokinesis | 2 | 2011 | 21 | 0.110 |
Why?
|
| Dioxolanes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2017 | 330 | 0.110 |
Why?
|
| Immunization | 1 | 2015 | 300 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 129 | 0.110 |
Why?
|
| GATA3 Transcription Factor | 1 | 2014 | 41 | 0.110 |
Why?
|
| Drug Repositioning | 1 | 2014 | 29 | 0.110 |
Why?
|
| Virus Replication | 1 | 2017 | 593 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 149 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2016 | 407 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 83 | 0.100 |
Why?
|
| Drug Design | 1 | 2014 | 153 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2014 | 155 | 0.100 |
Why?
|
| Cell Survival | 3 | 2024 | 841 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2012 | 33 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 576 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 237 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 428 | 0.090 |
Why?
|
| Hydrolases | 1 | 2012 | 60 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 228 | 0.090 |
Why?
|
| Immunochemistry | 1 | 2011 | 24 | 0.090 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 32 | 0.090 |
Why?
|
| Fertility | 1 | 2014 | 251 | 0.090 |
Why?
|
| Anaphase | 1 | 2011 | 13 | 0.090 |
Why?
|
| Cytological Techniques | 1 | 2011 | 17 | 0.090 |
Why?
|
| Cells | 1 | 2011 | 19 | 0.090 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2011 | 30 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 359 | 0.090 |
Why?
|
| Tissue Fixation | 1 | 2011 | 36 | 0.090 |
Why?
|
| Coloring Agents | 1 | 2011 | 69 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2004 | 219 | 0.090 |
Why?
|
| Neoplasms | 2 | 2017 | 2856 | 0.090 |
Why?
|
| Estrogen Receptor Modulators | 2 | 2009 | 39 | 0.090 |
Why?
|
| Counseling | 2 | 2023 | 233 | 0.090 |
Why?
|
| Bacterial Proteins | 3 | 2019 | 913 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 16 | 0.090 |
Why?
|
| Adult | 9 | 2025 | 30463 | 0.090 |
Why?
|
| Citrulline | 1 | 2012 | 116 | 0.090 |
Why?
|
| Morpholines | 3 | 2017 | 65 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2002 | 234 | 0.080 |
Why?
|
| Lipogenesis | 1 | 2011 | 62 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 761 | 0.080 |
Why?
|
| RNA Polymerase II | 2 | 2010 | 90 | 0.080 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2010 | 23 | 0.080 |
Why?
|
| Vaccination | 1 | 2015 | 1004 | 0.080 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2021 | 34 | 0.080 |
Why?
|
| Binding Sites | 3 | 2003 | 1187 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 361 | 0.080 |
Why?
|
| Vitreous Body | 2 | 1989 | 52 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 270 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 408 | 0.080 |
Why?
|
| Hospitals | 2 | 2023 | 428 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2010 | 70 | 0.080 |
Why?
|
| Retina | 3 | 1989 | 445 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2013 | 754 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 534 | 0.080 |
Why?
|
| Apoptosis | 3 | 2024 | 1811 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2009 | 108 | 0.070 |
Why?
|
| HIV Infections | 1 | 2021 | 1952 | 0.070 |
Why?
|
| Young Adult | 4 | 2025 | 9665 | 0.070 |
Why?
|
| Testosterone Congeners | 1 | 2008 | 15 | 0.070 |
Why?
|
| Benzopyrans | 1 | 2008 | 22 | 0.070 |
Why?
|
| Oxazoles | 1 | 2008 | 20 | 0.070 |
Why?
|
| Thiophenes | 1 | 2009 | 68 | 0.070 |
Why?
|
| Protein Transport | 3 | 2020 | 349 | 0.070 |
Why?
|
| Butyrates | 1 | 2008 | 41 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4442 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2009 | 246 | 0.070 |
Why?
|
| Rats | 6 | 2024 | 3392 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2025 | 361 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1560 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 379 | 0.070 |
Why?
|
| Retinal Degeneration | 2 | 1986 | 97 | 0.070 |
Why?
|
| Tumor Burden | 2 | 2021 | 229 | 0.070 |
Why?
|
| Piperidines | 1 | 2009 | 224 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1597 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 286 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2011 | 871 | 0.070 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2020 | 122 | 0.070 |
Why?
|
| Basement Membrane | 2 | 1986 | 38 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 890 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 1988 | 266 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2013 | 158 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 136 | 0.060 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 39 | 0.060 |
Why?
|
| Fluorescence Recovery After Photobleaching | 2 | 2004 | 13 | 0.060 |
Why?
|
| Glycosaminoglycans | 1 | 1986 | 29 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 202 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 135 | 0.060 |
Why?
|
| Cell Separation | 1 | 2007 | 219 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 851 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 3254 | 0.060 |
Why?
|
| Polylysine | 1 | 2006 | 11 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2311 | 0.060 |
Why?
|
| Choroid | 1 | 1986 | 23 | 0.060 |
Why?
|
| Aged | 2 | 2021 | 20395 | 0.060 |
Why?
|
| Formaldehyde | 1 | 2006 | 36 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2020 | 769 | 0.060 |
Why?
|
| Lens, Crystalline | 1 | 1986 | 97 | 0.060 |
Why?
|
| Protein Isoforms | 3 | 2012 | 404 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 1293 | 0.060 |
Why?
|
| Photobleaching | 1 | 2004 | 6 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2025 | 273 | 0.060 |
Why?
|
| Progesterone | 1 | 2006 | 427 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2007 | 449 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 28 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 348 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 187 | 0.050 |
Why?
|
| Chromones | 2 | 2015 | 24 | 0.050 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2004 | 21 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 280 | 0.050 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2004 | 92 | 0.050 |
Why?
|
| Gene Expression | 3 | 2017 | 1482 | 0.050 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2024 | 21 | 0.050 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2004 | 22 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2014 | 708 | 0.050 |
Why?
|
| Myotonic Dystrophy | 1 | 2005 | 118 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 1987 | 441 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 75 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2020 | 800 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2016 | 570 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 225 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2020 | 578 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 78 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2020 | 169 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 94 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2012 | 769 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 296 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2025 | 438 | 0.050 |
Why?
|
| Kinetics | 2 | 2007 | 1092 | 0.050 |
Why?
|
| Models, Biological | 2 | 2020 | 1373 | 0.050 |
Why?
|
| Ataxins | 1 | 2002 | 111 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 400 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2002 | 55 | 0.050 |
Why?
|
| Action Potentials | 1 | 2025 | 463 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1987 | 199 | 0.050 |
Why?
|
| Infant | 3 | 2024 | 12775 | 0.050 |
Why?
|
| Base Sequence | 1 | 2006 | 2759 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1230 | 0.050 |
Why?
|
| Ataxin-1 | 1 | 2002 | 158 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 193 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2002 | 130 | 0.050 |
Why?
|
| COS Cells | 3 | 2010 | 244 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3586 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2021 | 30 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 533 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2021 | 84 | 0.040 |
Why?
|
| Leupeptins | 1 | 2001 | 21 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 538 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 196 | 0.040 |
Why?
|
| Dactinomycin | 1 | 2001 | 48 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 187 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1398 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 34 | 0.040 |
Why?
|
| Palivizumab | 1 | 2021 | 46 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2025 | 821 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 147 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 7 | 0.040 |
Why?
|
| Pregnancy | 3 | 2019 | 7376 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 94 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1760 | 0.040 |
Why?
|
| Family | 1 | 2023 | 576 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 270 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 89 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 563 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2010 | 112 | 0.040 |
Why?
|
| Cause of Death | 1 | 2022 | 487 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2022 | 395 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1569 | 0.040 |
Why?
|
| Diffusion | 1 | 2019 | 55 | 0.040 |
Why?
|
| Child | 3 | 2024 | 25121 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 226 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 415 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.040 |
Why?
|
| Insulin Resistance | 2 | 2015 | 665 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2543 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2020 | 437 | 0.040 |
Why?
|
| Capillaries | 3 | 1987 | 67 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 229 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2020 | 511 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 126 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 168 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 176 | 0.030 |
Why?
|
| Cattle | 3 | 1988 | 537 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 21 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 239 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 64 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 85 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 64 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4511 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 70 | 0.030 |
Why?
|
| Giant Cells | 1 | 2017 | 34 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 347 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 82 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2017 | 89 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2016 | 39 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 154 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 130 | 0.030 |
Why?
|
| Gonanes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Promegestone | 1 | 2015 | 21 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 228 | 0.030 |
Why?
|
| Mifepristone | 1 | 2015 | 87 | 0.030 |
Why?
|
| Metabolome | 1 | 2018 | 316 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 131 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8350 | 0.030 |
Why?
|
| Dengue | 1 | 2017 | 120 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 236 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1559 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 79 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1919 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 111 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 113 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 223 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 105 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 291 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 79 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 521 | 0.030 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 175 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2017 | 510 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 686 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 16 | 0.030 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 22 | 0.030 |
Why?
|
| Piperidones | 1 | 2014 | 9 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 695 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 414 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 37 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 192 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 52 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 67 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 87 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 4961 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 302 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 251 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 504 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 253 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 361 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2019 | 962 | 0.030 |
Why?
|
| Perilipin-1 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Decidua | 1 | 2014 | 135 | 0.020 |
Why?
|
| Lung | 1 | 2021 | 1517 | 0.020 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2012 | 5 | 0.020 |
Why?
|
| Castration | 1 | 2012 | 31 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 493 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 628 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 47 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 49 | 0.020 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2012 | 4 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 100 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 99 | 0.020 |
Why?
|
| Lipase | 1 | 2012 | 87 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 46 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2011 | 51 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 456 | 0.020 |
Why?
|
| Endometriosis | 1 | 2014 | 168 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 578 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 88 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2012 | 222 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2014 | 742 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 783 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Cell Division | 2 | 1989 | 720 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 576 | 0.020 |
Why?
|
| Nandrolone | 1 | 2010 | 6 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10573 | 0.020 |
Why?
|
| Propanolamines | 1 | 2010 | 18 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 873 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 60 | 0.020 |
Why?
|
| Aurora Kinase C | 1 | 2009 | 2 | 0.020 |
Why?
|
| Kinetochores | 1 | 2009 | 4 | 0.020 |
Why?
|
| Aurora Kinase B | 1 | 2009 | 7 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 204 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2010 | 54 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2009 | 46 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 119 | 0.020 |
Why?
|
| Membranes | 1 | 1989 | 15 | 0.020 |
Why?
|
| Neuregulin-1 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 81 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1989 | 28 | 0.020 |
Why?
|
| Microtubules | 1 | 2009 | 118 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 72 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1989 | 126 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 424 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1989 | 101 | 0.020 |
Why?
|
| Karyotyping | 1 | 1989 | 312 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 14357 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 398 | 0.020 |
Why?
|
| Lysine | 1 | 2009 | 173 | 0.020 |
Why?
|
| Lipids | 1 | 2011 | 550 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2010 | 374 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4775 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 125 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 686 | 0.020 |
Why?
|
| Endothelium | 1 | 1987 | 63 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 6147 | 0.020 |
Why?
|
| Genes, bcl-1 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Progesterone Congeners | 1 | 2006 | 5 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2006 | 35 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 309 | 0.020 |
Why?
|
| Microcirculation | 1 | 1987 | 102 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 57 | 0.020 |
Why?
|
| Chromatography | 1 | 1986 | 35 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 3710 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17026 | 0.020 |
Why?
|
| Imidazolidines | 1 | 1986 | 5 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1986 | 48 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2111 | 0.020 |
Why?
|
| Actins | 1 | 1988 | 311 | 0.020 |
Why?
|
| Galactose | 1 | 1986 | 53 | 0.010 |
Why?
|
| Photoreceptor Cells | 1 | 1986 | 91 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 1279 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 27758 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1352 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2004 | 4 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1986 | 823 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2004 | 49 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2004 | 17 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 85 | 0.010 |
Why?
|
| Co-Repressor Proteins | 1 | 2004 | 37 | 0.010 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2004 | 11 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1986 | 104 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 24 | 0.010 |
Why?
|
| Collagen | 1 | 1986 | 292 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 102 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 1765 | 0.010 |
Why?
|
| Cyclin A | 1 | 2003 | 17 | 0.010 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 20 | 0.010 |
Why?
|
| Cyclin E | 1 | 2003 | 32 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2003 | 46 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 186 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 298 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 757 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 46 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 148 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 365 | 0.010 |
Why?
|
| Acetylation | 1 | 2002 | 181 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 478 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1493 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 757 | 0.010 |
Why?
|
| Autoradiography | 1 | 1989 | 65 | 0.000 |
Why?
|
| Mathematics | 1 | 1989 | 72 | 0.000 |
Why?
|
| Lens Capsule, Crystalline | 1 | 1986 | 24 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 460 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 260 | 0.000 |
Why?
|
| Kidney Glomerulus | 1 | 1986 | 80 | 0.000 |
Why?
|
| Dogs | 1 | 1986 | 604 | 0.000 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1986 | 140 | 0.000 |
Why?
|
| Amino Acids | 1 | 1986 | 615 | 0.000 |
Why?
|
| Cornea | 1 | 1986 | 551 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1986 | 1311 | 0.000 |
Why?
|
| Age Factors | 1 | 1986 | 2791 | 0.000 |
Why?
|
| Brain | 1 | 1986 | 3039 | 0.000 |
Why?
|